Ireland - English - HPRA (Health Products Regulatory Authority)

virbac de portugal laboratorios - ivermectin - solution for injection - 10 mg/ml - endectoparasiticides - bovine

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac de portugal laboratorios - ivermectin - solution for injection - 10 mg/ml - endectoparasiticides - bovine ovine porcine

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac de portugal laboratorios - ivermectin - pour-on solution - 5 mg/ml - endectoparasiticides - bovine

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac de portugal laboratorios - ivermectin clorsulon - solution for injection - mg/ml - endectoparasiticides - bovine

European Union - English - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy in post-menopausal women and in men at increased risk of fracture. treatment of paget's disease of the bone.,

European Union - English - EMA (European Medicines Agency)

sandoz gmbh - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole sandoz is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole sandoz is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment. aripiprazole sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.,

European Union - English - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - nelarabine - precursor t-cell lymphoblastic leukemia-lymphoma - antineoplastic agents - nelarabine is indicated for the treatment of patients with t-cell acute lymphoblastic leukaemia (t-all) and t-cell lymphoblastic lymphoma (t-lbl) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.,

European Union - English - EMA (European Medicines Agency)

ecuphar - meloxicam - anti inflammatory and antirheumatic products - dogs; cats - oral suspension:dogs:alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.solution for injection:dogs:alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery.cats:reduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.

European Union - English - EMA (European Medicines Agency)

intervet international bv - indoxacarb - ectoparasiticides for topical use, incl. insecticides, indoxacarb - dogs; cats - treatment and prevention of flea infestation.for dogs and cats: treatment and prevention of flea infestation.the veterinary medicinal product can be used as part of a treatment strategy for flea-allergy dermatitis. developing stages of fleas in the pet's immediate surroundings are killed following contact with activyl-treated pets.

European Union - English - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - topotecan - ovarian neoplasms; uterine cervical neoplasms; small cell lung carcinoma - antineoplastic agents - hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.